These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Reported results 2004-000242-20 A randomised trial of the European and American Osteosarcoma Study Group to optimize treatment strategies for resectable osteosarcoma based on histological response to pre-operative chemotherapy 2018-12-31 due-trials
Ongoing 2004-000799-15 DOES BENFOTIAMINE SUPPLEMENTATION REDUCE SERUM LEVELS OF ADVANCED GLYCATION END PRODUCTS AND BIOCHEMICAL MARKERS OF VASCULAR DYSFUNCTION IN TYPE 1 DIABETES? not-yet-due
Not reported 2004-002187-22 Scandinavian Candesartan Acute Stroke Trial 2010-09-15 due-trials
Ongoing 2004-002732-25 Safety and efficacy of levosimendan in patients with acute myocardial infarction complicated by symptomatic left ventricular failure not-yet-due
Ongoing 2004-004488-31 Does cyclosporine A reduce the insulin secretion from the pancreas? not-yet-due
Listed as ongoing, but also has a completion date 2005-000217-35 EpSSG RMS 2005 a protocol for non metastatic rhabdomyosarcoma 2016-12-31 bad-data
Listed as ongoing, but also has a completion date 2005-002003-17 High-dose therapy with autologous stem cell support in first line treatment of mantle cell lymphoma - Yttrium-90-ibritumomab tiuxetan in combination with BEAM or BEAC to improve outcome for patients n... 2015-04-13 bad-data
Ongoing 2005-004211-30 Penicillin G and an aminoglycoside versus meropenem as initial empiric antibiotic therapy in lymphoma and leukemia patients with febrile neutropenia not-yet-due
Ongoing 2005-004486-42 Catheter-directed Venous Thrombolysis (CaVenT) in Acute Iliofemoral Vein Thrombosis - an open Randomized, Controlled, Clinical Trial not-yet-due
Ongoing 2005-005494-29 Rifampin combination therapy versus monotherapy in early staphylococcal infections after total hip and knee arthroplasty not-yet-due
Reported results 2005-005918-20 Rituximab as second line treatment for ITP. A Multicentre, Randomized, Double blind, Placebo-controlled, Phase III study. 2013-01-15 due-trials
Completed, but no date Terminated 2007-000518-34 Effect of beta blockade on left ventricular remodeling and function in aortic regurgitation bad-data
Ongoing 2008-003006-34 A multicenter, randomized, phase II clinical trial to evaluate the effect of Avastin in combination with neoadjuvant treatment regimens on the molecular and metabolic characteristics and changes in th... not-yet-due
Ongoing 2008-006253-41 Phase I/II trial for vaccine therapy with hTERT-, survivin- and tumor cell derived mRNA + ex vivo T cell expansion and reinfusion in patients with metastatic malignant melanoma not-yet-due
Ongoing 2009-011112-37 Dexmedetomidine versus midazolam til sedasjon av pediatriske intensivpasienter ved Oslo Universitetssykehus. not-yet-due
No trial status on register 2009-012667-34 BRONCHIOLITIS, OPTIMAL TREATMENT IN INFANTS AND PROGNOSIS bad-data
Ongoing 2009-015316-17 Perioperativ administrasjon av pregabalin ved laparoskopisk living donor nefrektomi (L-LDN) - et adjuvans til peroral analgetisk behandling - en randomisert kontrollert studie not-yet-due
Ongoing 2009-016924-30 NorCAPITAL The Norwegian Study of Chronic Fatigue Syndrome in Adolescents: Pathophysiology and Intervention Trial not-yet-due
Exempt 2010-018770-20 Phase I/II trial of vaccine therapy in curative resected prostate cancer patients using autologous dendritic cells loaded with mRNA from primary prostate cancer tissue, hTERT and surviving. 2022-07-25 not-yet-due
Exempt 2010-020233-56 PHASE I/II TRIAL OF VACCINE THERAPY IN RELAPSED AND PLATINUM RESISTANT EPITHELIAL OVARIAN CANCER PATIENTS USING AUTOLOGOUS DENDRITIC CELLS LOADED WITH AMPLIFIED OVARIAN CANCER STEM CELL mRNA, hTERT ... not-yet-due
Ongoing 2011-001455-37 Prospective randomized interventional study. Compare the effect of bleomycin and Tetradecyl Sodium Sulphate (Fibrovein) in the treatment of venous malformations. Clinical neurological and neurophysiol... not-yet-due
Reported results Terminated 2011-002181-20 Naltrexone Implants for Alcoholism 2012-01-31 due-trials
Not reported 2011-002630-39 MICROVASCULAR RESISTANCE IN WOMEN WITH CHEST PAIN AND NO OR MINIMAL CORONARY ARTERY DISEASE 2016-06-09 due-trials
Completed, but no date, and reported results 2011-002734-39 Opioid Induced Hyperalgesia: possible to avoid by gradual reduction compared to acute withdrawal from remifentanil? bad-data
Exempt 2012-001852-20 A PHASE I/IIa STUDY OF UV1 VACCINATION IN PATIENTS WITH NON-SMALL CELL LUNG CANCER not-yet-due
Reported results 2012-002211-25 Prevention of bladder dysfunction in acute spinal cord injury A double-blind, randomized, placebo-controlled study to explore the effect of early treatment with Onabotulinumtoxin A in patients with ... 2019-03-12 due-trials
Exempt 2012-002411-26 A PHASE I/IIA STUDY OF UV1 VACCINATION IN PATIENTS WITH HORMONE-SENSITIVE METASTATIC PROSTATE CANCER. not-yet-due
Ongoing 2012-004418-32 Cabazitaxel as salvage treatment for cisplatin-resistant germ cell cancer not-yet-due
Ongoing 2012-004992-37 The effects of n-3 polyunsaturated fatty acids on glomerular filtration rate, proteinuria, fibrosis and inflammation in the kidney transplant and cardiovascular risk markers in kidney transplant recip... not-yet-due
Ongoing 2012-005335-83 A Randomized Open-label Study: Efficacy and safety of basiliximab combined with tacrolimus, mycophenolate and low-dose corticosteroids vs thymoglobulin, tacrolimus, mycophenolate and high-dose cortic... not-yet-due
Ongoing 2012-005651-17 Plexus brachialis block and circulation. Comparing effects on skin microcirculation and macro circulation of lidocain brachial plexus block with versus without epinephrine. not-yet-due
Exempt 2013-000560-28 PHASE I/II TRIAL OF MOC31PE IMMUNOTOXIN IN PERITONEAL CARCINOMATOSIS FROM COLORECTAL CARCINOMA. not-yet-due
Ongoing 2013-000793-30 The PedTac study Development of a pediatric pharmacokinetic population model for Tacrolimus not-yet-due
Ongoing 2013-000815-26 THE OSLO STUDY OF CLONIDINE IN ELDERLY PATIENTS WITH DELIRIUM not-yet-due
Ongoing 2013-000883-27 EFFECTS OF RIFAXIMIN, BY MODULATION OF THE GUT MICROBIOTA, ON MARKERS OF SYSTEMIC INFLAMMATION IN PATIENTS WITH COMMON VARIABLE IMMUNODEFICIENCY - AN EXPLORATORY OPEN-LABEL RANDOMIZED CONTROLLED TRIAL not-yet-due
Ongoing 2013-001363-23 N-of-1 trial: Actionable Target Identification in Metastatic Cancer for Palliative Systemic Therapy not-yet-due
Not reported 2013-002379-17 MECILLINAM FOR TREATMENT OF GENITAL CHLAMYDIA INFECTION IN ASYMPTOMATIC MEN. 2015-04-28 due-trials
Ongoing 2013-002408-15 Phase IV ipilimumab in melanoma A National, Multicenter, Interventional Study in Patients with Unresectable or Metastatic Melanoma not-yet-due
No trial status on register 2013-003731-29 Could working memory training with computer games be an alternative to stimulant medication for children and adolescents with attention deficits and epilepsy? Arbeidsminnetrening m dataspill hos ... bad-data
Ongoing 2013-004418-17 Improved breast cancer therapy (I-BCT-1) in the neoadjuvant and metastatic setting: A phase 2 clinical trial protocol studying biological rationale for the optimal selection of treatment regimens. not-yet-due
Reported results 2013-004505-14 Antibiotic treatment in patients with chronic low back pain and Modic Changes: a double-blind randomized placebo-controlled trial 2018-09-21 due-trials
Ongoing, reported early 2014-000507-27 The Clinical Carbetocin Myocardium Trial not-yet-due
Not reported 2014-000673-40 Prospective randomized trial between Percutaneous Needle Fasciotomy and Xiapex injection 2021-08-26 due-trials
Ongoing 2014-002636-13 Study of Antithrombotic Treatment after Intracerebral Haemorrhage (STATICH) not-yet-due
Ongoing 2014-003601-15 ACETYLSALICYLIC ACID AS SECONDARY PREVENTION IN COLORECTAL CANCER (ASAC TRIAL) A multi-centre, double-blinded, randomized, placebo-controlled clinical intervention trial with ASA in patients undergoin... not-yet-due
Reported results 2014-003614-87 Novel Imaging of the Eustachian Tube, a CT study using dilute iodixanol in an adult population 2017-12-31 due-trials
Ongoing 2014-004318-27 Intravenous bisphosphonate in stress fracture treatment -A randomised controlled double blinded multicenter trial Intravenøs bisfosfonat ved stressfrakturer -En randomisert kontrollert dobbelt blin... not-yet-due
Reported results Terminated 2014-004830-25 Kidney Cancer Integrated Therapy (KIT) - Personalized integrated therapy for patients with advanced kidney cancer 2017-01-23 due-trials
Not reported 2015-000192-27 GutHeart: Targeting Gut microbiota to treat Heart failure 2019-11-19 due-trials
Ongoing 2015-000307-10 AZD9291, an irreversible EGFR-TKI, in relapsed EGFR-mutated non-small cell lung cancer patients previously treated with an EGFR-TKI, coupled to extensive translational studies. not-yet-due
Exempt Terminated 2015-000577-13 Therapeutic effects of BNP in uncontrolled hypertensive patients 1 not-yet-due
Ongoing 2015-001673-40 INTRATHECAL CONTRAST-ENHANCED MAGNETIC RESONANCE IMAGING not-yet-due
Ongoing 2015-002198-40 Open label randomized phase II/III trial of dendritic cell immunotherapy against cancer stem cells in glioblastoma patients receiving standard therapy (DEN-STEM) not-yet-due
Ongoing 2015-002701-11 ADJUVANT CHEMOTHERAPY IN ELDERLY – GERIATRIC ASSESSMENT AND PROGNOSTIC GENE SIGNATURES not-yet-due
Other 2015-003350-41 The Diabetes Virus Detection and Intervention Trial (DiViDIntervention) not-yet-due
Not reported Terminated 2015-004747-39 A phase II study of pembrolizumab in patients with malignant peripheral nerve sheath tumor (MPNST), not eligible for curative surgery 2020-12-15 due-trials
Other 2016-000222-19 Effect of ALlopurinol in addition to hypothermia for hypoxic-ischemic Brain Injury on Neurocognitive Outcome ¿ a blinded randomized placebo-controlled parallel group multicenter trial for superiority ... not-yet-due
Ongoing 2016-000684-16 Brachial plexus block and rebound pain after radius fixation with a polar plate. not-yet-due
Ongoing 2016-001676-29 PROMO: A phase II study of Pembrolizumab in patients with Relapsed Or Metastatic Osteosarcoma not eligible for curative surgery not-yet-due
Completed, report not yet due 2016-003570-40 ALICE: A randomized placebo-controlled phase II study evaluating atezolizumab combined with immunogenic chemotherapy in patients with metastatic triple-negative breast cancer. 2023-04-25 not-yet-due
Ongoing 2016-003700-31 Effects of nutrition therapy on growth, metabolism and inflammation in immature infants; a double-blind randomized, controlled trial not-yet-due
Ongoing 2016-003774-40 Discontinuation of imatinib in patients with oligo-metastatic gastrointestinal stromal tumor that has become radiologically undetectable with treatment not-yet-due
Reported results 2016-004739-19 OSU6162 IN THE TREATMENT OF FATIGUE AND OTHER NEUROPSYCHOLOGICAL SEQUELAE AFTER ANEURYSMAL SUBARACHNOIDAL HEMORRHAGE - A DOUBLE-BLIND, RANDOMISED, PLACEBO-CONTROLLED STUDY 2019-09-13 due-trials
Listed as ongoing, but also has a completion date 2017-000220-10 A randomized phase IIb study evaluating immunogenic chemotherapy combined with ipilimumab and nivolumab in patients with luminal B breast cancer 2022-05-11 bad-data
Ongoing 2017-000586-72 KRd consolidation in myeloma patients with a positive PET-CT after standard first line treatment. A phase II study not-yet-due
Completed, report not yet due 2017-000614-39 Prevention of graft-versus-host disease in patients treated with allogeneic stem cell transplantation: Possible role of extracorporeal photophoresis Forebygging av transplantat-mot-vert-sykdom hos ... 2023-09-10 not-yet-due
Reported results 2017-001285-23 A comparison of analgesic and respiratory effects from tapentadol versus oxycodone after laparoscopic hysterectomy. 2019-02-28 due-trials
Not reported 2017-003673-34 Identification of non-responders to levothyroxine-therapy: development of biomarkers reflecting T4 and T3 action at the tissue level 2020-06-22 due-trials
Not reported 2017-004116-19 The AP-GELP Study: A randomized, placebo-controlled clinical trial on the effects of phosphodiesterase 4-inhibitor apremilast in female genital erosive lichen planus AP-GELP-studien: Behandling m... 2022-11-22 due-trials
Completed, report not yet due 2017-004861-29 BackToBasic: The effect of Infliximab in patients with chronic low back pain and Modic changes. A randomized, double blind, placebo-controlled, multicenter trial 2023-09-29 not-yet-due
Ongoing 2017-005097-19 Cholesterol lowering with EVOLocumab to prevent cardiac allograft Vasculopathy in De-novo heart transplant recipients not-yet-due
Other 2018-000515-24 An overarching study for children and adults with Frontline and Relapsed RhabdoMyoSarcoma Uno studio globale su bambini e adulti con RabdoMioSarcoma frontline e recidivante not-yet-due
Ongoing 2018-000590-75 BEta-Blocker Treatment after Acute Myocardial Infarction in revascularized patients with preserved left ventricular systolic function (BETAMI trial) not-yet-due
Not reported 2018-000724-34 Norwegian Nucleoside Analogue Stop Study (Nuc-STOP) - A randomized open-label trial in HBeAg negative chronic hepatitis B, aiming at achieving a functional Cure 2023-01-31 due-trials
Completed, report not yet due Terminated 2018-000823-15 Glucose metabolism in South Asian women with impaired glucose tolerance or impaired fasting glucose. DIAbetes in South Asians – DIASA 3 A 12-week intervention trial with oral antidiabetic medication ... 2023-06-08 not-yet-due
Not reported 2018-002338-19 BUSCLAB - A DOUBLE BLIND RANDOMIZED PLACEBO-CONTROLLED TRIAL INVESTIGATING THE EFFECT OF INTRAVENOUS BUTYLSCOPOLAMINE BROMIDE TO TREAT SLOW PROGRESS IN LABOR 2021-12-16 due-trials
Ongoing 2018-002546-36 TENECTEPLASE IN CENTRAL RETINAL ARTERY OCCLUSION STUDY (TenCRAOS): A PROSPECTIVE, RANDOMIZED-CONTROLLED, DOUBLE-DUMMY, DOUBLE-BLIND PHASE 3 MULTI-CENTRE TRIAL OF TNK 0.25 MG/KG + PLACEBO VS. ASA + PL... not-yet-due
Completed, but no date 2018-003939-30 Determination of analgesic equipotent doses of inhaled metoxyflurane vs. intravenous fentanyl using cold pressor test (CPT) in volunteers: A randomized, double blind, placebo-controlled crossover stud... bad-data
Ongoing 2018-004119-36 Altered tumor oxygenation by Metformin, a potential step in overcoming radiotherapy resistance in locally advanced cervical cancer. not-yet-due
Ongoing 2018-004580-31 Comparative effectiveness of intestinal microbiota versus vancomycin for primary Clostridium difficile infection – randomized trials. not-yet-due
Ongoing 2019-000889-38 Strategies towards personalised treatment in Juvenile Idiopathic Arthritis (JIA): An open randomised multicentre blinded-assessor trial assessing the effectiveness of intra-articular glucocorticoid ... not-yet-due
Completed, report not yet due 2019-001492-37 Zoledronic acid as adjuvant therapy in neovascular Age-related Macular Degeneration (The Z-AMD study): a randomized controlled pilot study 2024-01-24 not-yet-due
Ongoing 2019-001505-24 Norwegian study of Oral cladribine versus Rituximab in Multiple Sclerosis (NOR-MS). A prospective randomized open-label blinded endpoint (PROBE) multicenter non-inferiority study. not-yet-due
Ongoing 2019-002037-11 Intravenous Iron supplement for Iron deficiency in patients with Severe Aortic Stenosis not-yet-due
Ongoing 2019-002388-87 EXtended CriteriA treatment for LIver Metastases with heavy tumour BURden not-yet-due
Ongoing 2019-002476-14 IMMUNOSUPPRESSIVE DRUGS AND GUT MICROBIOME: PHARMACOKINETIC- AND MICROBIOME DIVERSITY EFFECTS not-yet-due
Ongoing 2019-002529-31 SAFETY AND EFFICACY OF SHINGRIX VACCINATION IN VARICELLA NAÏVE RENAL TRANSPLANT RECIPIENTS not-yet-due
Ongoing 2019-002537-11 Durvalumab (MEDI4736) After chemoRadioTherapy (DART) for NSCLC patients – a phase II translational and biomarker study investigating PDL1 positive and negative patients not-yet-due
Ongoing 2019-002539-27 Association between intrarenal tacrolimus concentration and development of renal interstitial fibrosis in renal transplant recipients not-yet-due
Other 2019-002721-30 Nivolumab and ipilimumab +/- UV1 vaccination as second line treatment in patients with malignant mesothelioma (the NIPU-study) not-yet-due
Reported results 2019-004144-29 Methoxyflurane and fentanyl in hypovolemia induced by lower body negative pressure in healthy volunteers; A randomized, placebo-controlled crossover study 2022-03-18 due-trials
Not reported 2019-004400-35 The ReSScue trial. Aiming to Reduce disease-related gastro-intestinal symptoms in patients with Systemic Sclerosis by repeat intestinal infusions of Anaerobic Cultivated Human Intestinal Microbiome (A... 2022-06-27 due-trials
Ongoing 2019-004401-27 The REMNANT (RElapse from Mrd Negativity As iNdication for Treatment) study not-yet-due
Ongoing 2019-004831-21 10 to 12 year extended follow-up of the SCHEDULE study (SCANDINAVIAN HEART TRANSPLANT EVEROLIMUS DE NOVO STUDY WITH EARLY CNI AVOIDANCE) not-yet-due
Ongoing 2020-000638-17 ZOLEDRONATE EARLY TO HIP FRACTURE PATIENTS – SAFE AND EFFECTIVE? A DOUBLE-BLINDED RANDOMIZED CONTROLLED TREATMENT STRATEGY TRIAL ON ZOLEDRONATE IN HIP FRACTURE PATIENTS THE ZEBRA TRIAL not-yet-due
Ongoing 2020-000982-18 The NOR Solidarity multicenter trial on the efficacy of different anti-viral drugs in SARS-CoV-2 infected patients (COVID-19). not-yet-due
Ongoing 2020-001656-18 Inhaled Nitric Oxide As A Bridge To Mechanical Ventilation In Patients With Suspected Covid-19 Respiratory Failure not-yet-due
Ongoing 2020-002307-18 A phase IIa, double-blind, randomised, placebo-controlled study on the efficacy and tolerability of a 14-day treatment with teriflunomide 14 mg tablets vs. placebo in subjects with well-controlled coe... not-yet-due
Not reported 2020-002337-15 TOPICAL GENTAMICIN TREATMENT OF PATIENTS WITH EPIDERMOLYSIS BULLOSA DUE TO NONSENSE MUTATIONS (THE GENTELBULL STUDY) 2022-05-01 due-trials
Ongoing 2020-002621-29 Effect of patiromer on pharmacokinetics of immunosuppressive drugs in renal transplant recipients not-yet-due
Ongoing 2020-002777-95 Sequential neoadjuvant ifosfamide and doxorubicin in localized high-grade soft tissue sarcoma of extremities and trunk wall not-yet-due
Ongoing 2020-003395-41 An open-label single arm interventional phase 2 study to investigate outcome of individualized treatment based on pharmacogenomic profiling and ex vivo drug sensitivity testing of patient-derived orga... not-yet-due
Ongoing 2020-003407-34 A randomized clinical three-arm trial comparing inflammation and cystoid macular edema for the medication regimens preoperative and postoperative topical NSAIDs to only postoperative topical NSAIDs to... not-yet-due
Ongoing 2020-003408-15 A randomized clinical two-arm trial comparing inflammation and cystoid macular edema for the medication regimens postoperative topical NSAIDs and steroids to only postoperative topical steroids in pat... not-yet-due
Ongoing 2020-004414-35 Improving public cancer care by implementing precision medicine in Norway not-yet-due
Ongoing 2020-004425-23 A Phase 2, single arm, open label, multicenter study to assess minimal residual disease after isatuximab in combination with bortezomib and lenalidomide with minimal dexamethasone in patients with new... not-yet-due
Ongoing 2020-004944-27 NORMOTHERMIC INTRAPERITONEAL CHEMOTHERAPY IN PERITONEAL METASTASES FROM COLORECTAL CANCER – FEASIBILITY STUDY (NIPEC-OXA) not-yet-due
Ongoing 2020-005123-36 A randomized, double-blind, parallel-group non-inferiority phase III withdrawal trial of paracetamol versus placebo in conjunction with opioids for moderate to severe cancer-related pain not-yet-due
Ongoing 2020-005938-15 Health risks and treatment of anabolic-androgenic steroid (AAS) induced hypogonadism among men – a pilot study exploring off-label use of clomiphene citrate to reduce symptoms of androgen deficiency a... not-yet-due
Ongoing 2021-000392-37 A double-blind randomized placebo-controlled four-arm trial to assess the efficacy of oral bicarbonate and intravenous butylscopolamine bromide to facilitate spontaneous (non-operative) delivery in pr... not-yet-due
Other 2021-000541-41 European DisCoVeRy for Solidarity: An Adaptive Pandemic and Emerging Infection Platform Trial not-yet-due
Ongoing 2021-000549-42 PreMeFen not-yet-due
Ongoing 2021-001554-61 Anti-Coagulation versus AcetylSalicylic Acid after Transcatheter Aortic Valve Implantation (ACASA-TAVI) not-yet-due
Ongoing 2021-001645-12 Alpha 2 adrenergic receptor agonists for the prevention of delirium and cognitive decline after open heart surgery (ALPHA2PREVENT): randomised controlled trial. not-yet-due
Other 2021-003175-34 DAPARHT: DAPAgliflozin for Renal protection in Heart Transplant recipients not-yet-due
Reported results 2021-003238-35 Effects of supplemental oxygen on systemic and cerebral hemodynamics in experimental hypovolemia: A randomized, phase IV, crossover study to study the effect of supplemental oxygen vs. room air on cer... 2022-06-14 due-trials
Ongoing 2021-003266-13 A PHASE 2 RANDOMISED OPEN TWO-ARM STUDY TO ASSESS THE TOLERABILITY AND EFFICACY OF IMMUNOTHERAPY COMBINED WITH EXTENSIVE RADIATIOTHERAPY FOR THE TREATMENT OF STAGE IV NON-SMALL CELL LUNG CANCER not-yet-due
Ongoing 2021-003618-37 REVACCINATION OF IMMUNOSUPPRESSED PATIENTS WITH POOR/NO SARS-COV-2 VACCINE RESPONSE. not-yet-due
Ongoing 2021-005850-27 An open label phase II trial in hormone receptor positive breast cancer patients randomized to neoadjuvant chamotherapy with or without bevacizumab (if ViRP signature positive) followed by endocrine t... not-yet-due
Completed, but no date Terminated 2021-006960-26 COVID-19 PROPHYLAXIS IN IMMUNOSUPPRESSED PATIENTS WITH NO/POOR SARS-COV-2 VACCINE RESPONSE USING LONG-ACTING ANTIBODIES (AZD7442) bad-data
Ongoing 2022-001184-28 Perioperative Propranolol in Robotic Assisted Laparoscopic Prostatectomy - A Pilot Study A parallel-group, phase 2, double-blind, 2-arm study to assess the feasibility of conducting a formal larger r... not-yet-due
Ongoing 2022-002428-10 CAN DAPAGLIFLOZIN PRESERVE STRUCTURE AND FUNCTION IN TRANSPLANTED KIDNEYS? not-yet-due